The purpose of looking at the association between responders in the two clinical trials and ACE genotype was not to detect a small theoretical association, in which case this subgroup analyses would be underpowered, but to see whether there was an association so strong that it would be valuable in clinical use predicting response in migraine – prophylactic treatment. Here, ACE is linked to migraine disorder.